Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BIERMAN PJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 99 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bierman, PJ
      Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma - The Picozzi et al article reviewed

      ONCOLOGY-NEW YORK
    2. Demirkazik, A; Kessinger, A; Armitage, JO; Bierman, PJ; Lynch, J; Vose, J; Chan, W; Sharp, JG
      Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation

      BONE MARROW TRANSPLANTATION
    3. Vose, JM; Bierman, PJ; Weisenburger, DD; Lynch, JC; Bociek, G; Chan, WC; Greiner, TC; Armitage, JO
      Autologous hematopoietic stem cell transplantation for mantle cell lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    4. Vose, JM; Colcher, D; Gobar, L; Bierman, PJ; Augustine, S; Tempero, M; Leichner, P; Lynch, JC; Goldenberg, D; Armitage, JO
      Phase I/II trial of multiple dose (131)iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    5. Weisenburger, DD; Gascoyne, RD; Bierman, PJ; Shenkier, T; Horsman, DE; Lynch, JC; Chan, WC; Greiner, TC; Connors, JM; Vose, JM; Armitage, JO; Sanger, WG
      Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma

      LEUKEMIA & LYMPHOMA
    6. Bierman, PJ
      High-dose therapy for follicular lymphoma - The Freedman/Friedberg/Gribbenarticle reviewed

      ONCOLOGY-NEW YORK
    7. Weisenburger, DD; Vose, JM; Greiner, TC; Lynch, JC; Chan, WC; Bierman, PJ; Dave, BJ; Sanger, WG; Armitage, JO
      Mantle cell lymphoma, a clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group

      AMERICAN JOURNAL OF HEMATOLOGY
    8. Singh, RK; Varney, ML; Ino, K; Vose, JM; Bierman, PJ; Talmadge, JE
      Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients

      EXPERIMENTAL HEMATOLOGY
    9. Bierman, PJ
      Allogeneic bone marrow transplantation for lymphoma

      BLOOD REVIEWS
    10. Pavletic, ZS; Arrowsmith, ER; Bierman, PJ; Goodman, SA; Vose, JM; Tarantolo, SR; Stein, RS; Bociek, G; Greer, JP; Wu, CD; Kollath, JP; Weisenburger, DD; Kessinger, A; Wolff, SN; Armitage, JO; Bishop, MR
      Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

      BONE MARROW TRANSPLANTATION
    11. Bishop, MR; Tarantolo, SR; Geller, RB; Lynch, JC; Bierman, PJ; Pavletic, ZS; Vose, JM; Kruse, S; Dix, SP; Morris, ME; Armitage, JO; Kessinger, A
      A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation

      BLOOD
    12. Gale, RP; Park, RE; Dubois, R; Bierman, PJ; Fisher, RI; Loh, KK; Peterson, BA; Phillips, GL; Portlock, CS; Rosenblum, D; Armitage, JO
      Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma (vol 32, pg 139, 1998)

      LEUKEMIA & LYMPHOMA
    13. Tezcan, H; Vose, JM; Bast, M; Bierman, PJ; Kessinger, A; Armitage, JO
      Limited stage I and II follicular non-Hodgkin's lymphoma: The Nebraska Lymphoma Study Group experience

      LEUKEMIA & LYMPHOMA
    14. Bierman, PJ
      High-dose therapy with stem-cell transplantation in the malignant lymphomas - The Winter article reviewed

      ONCOLOGY-NEW YORK
    15. Abou-Elella, AA; Weisenburger, DD; Vose, JM; Kollath, JP; Lynch, JC; Bast, MA; Bierman, PJ; Greiner, TC; Chan, WC; Armitage, JO
      Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 43patients from the Nebraska Lymphoma Study Group

      JOURNAL OF CLINICAL ONCOLOGY
    16. Baker, KS; Gordon, BG; Gross, TG; Abromowitch, MA; Lyden, ER; Lynch, JC; Vose, JM; Armitage, JO; Coccia, PF; Bierman, PJ
      Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents

      JOURNAL OF CLINICAL ONCOLOGY
    17. Lazarus, HM; Rowlings, PA; Zhang, MJ; Vose, JM; Armitage, JO; Bierman, PJ; Gajewski, JL; Gale, RP; Keating, A; Klein, JP; Miller, CB; Phillips, GL; Reece, DE; Sobocinski, KA; van Besien, K; Horowitz, MM
      Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry

      JOURNAL OF CLINICAL ONCOLOGY
    18. Ageitos, AG; Varney, ML; Bierman, PJ; Vose, JM; Warkentin, PI; Talmadge, JE
      Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products

      BONE MARROW TRANSPLANTATION
    19. Bierman, PJ; Cavalli, F; Armitage, JO
      Unusual syndromes in Hodgkin's disease

      HODGKIN'S DISEASE
    20. Armitage, JO; Goldstone, AH; Carella, AM; Schmitz, N; Phillips, GL; Bierman, PJ
      Role of bone marrow transplantation in Hodgkin's disease

      HODGKIN'S DISEASE
    21. Pavletic, ZS; Bierman, PJ; Armitage, JO
      Dose response and dose escalation

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    22. KESSINGER A; BIERMAN PJ; COWLES MK; ANDERSON JR; ARMITAGE JO; BISHOP MR; VOSE JM
      MOBILIZED VERSUS NON-MOBILIZED PERIPHERAL STEM-CELL TRANSPLANTATION AFTER HIGH-DOSE THERAPY FOR LOW-GRADE NONHODGKIN LYMPHOMA - EFFECT ON FAILURE-FREE SURVIVAL

      Cancer research, therapy & control
    23. BIERMAN PJ
      RANDOMIZED TRIALS OF TRANSPLANTATION FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Leukemia & lymphoma (Print)
    24. Gale, RP; Park, RE; Dubois, R; Bierman, PJ; Fisher, RI; Loh, KK; Peterson, BA; Phillips, GL; Portlock, CS; Rosenblum, D; Armitage, JO
      Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma

      LEUKEMIA & LYMPHOMA
    25. PAVLETIC ZS; BIERMAN PJ; VOSE JM; BISHOP MR; WU CD; PIERSON JL; KOLLATH JP; WEISENBURGER DD; KESSINGER A; ARMITAGE JO
      HIGH-INCIDENCE OF RELAPSE AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA

      Annals of oncology
    26. VOSE JM; BIERMAN PJ; LYNCH JC; WEISENBURGER DD; KESSINGER A; CHAN WC; GREINER TC; ARMITAGE JO
      EFFECT OF FOLLICULARITY ON AUTOLOGOUS TRANSPLANTATION FOR LARGE-CELL NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    27. HAUKE RJ; GREINER TC; SMIR BN; VOSE JM; TARANTOLO SR; BASHIR RM; BIERMAN PJ
      EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - REPORT OF 2 CASES

      Bone marrow transplantation
    28. PAVLETIC ZS; JOSHI SS; PIRRUCCELLO SJ; TARANTOLO SR; KOLLATH J; REED EC; BIERMAN PJ; VOSE JM; WARKENTIN PI; GROSS TG; NASRATI K; ARMITAGE JO; KESSINGER A; BISHOP MR
      LYMPHOCYTE RECONSTITUTION AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES

      Bone marrow transplantation
    29. Brand, RE; DiBaise, JK; Quigley, EMM; Gobar, LS; Harmon, KS; Lynch, JC; Bierman, PJ; Bishop, MR; Tarantolo, SR
      Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation

      LANCET
    30. BISHOP MR; TARANTOLO SR; JACKSON JD; ANDERSON JR; SCHMITPOKORNY K; ZACHARIAS D; PAVLETIC ZS; PIRRUCCELLO SJ; VOSE JM; BIERMAN PJ; WARKENTIN PI; ARMITAGE JO; KESSINGER A
      ALLOGENEIC-BLOOD STEM-CELL COLLECTION FOLLOWING MOBILIZATION WITH LOW-DOSE GRANULOCYTE-COLONY-STIMULATING FACTOR

      Journal of clinical oncology
    31. PAVLETIC ZS; BISHOP MR; TARANTOLO SR; MARTINALGARRA S; BIERMAN PJ; VOSE JM; REED EC; GROSS TG; KOLLATH J; NASRATI K; JACKSON JD; ARMITAGE JO; KESSINGER A
      HEMATOPOIETIC RECOVERY AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION COMPARED WITH BONE-MARROW TRANSPLANTATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Journal of clinical oncology
    32. VOSE JM; PANDITE AN; BEVERIDGE RA; GELLER RB; SCHUSTER MW; ANDERSON JE; LEMAISTRE CF; AHMED T; GRANENA A; KEATING A; RANADA JMF; STIFF PJ; TABBARA I; LONGO W; COPELAN EA; NICHOLS C; SMITH A; TOPOLSKY DL; BIERMAN PJ; LEBSACK ME; LANGE M; GARRISON L
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INTERLEUKIN-3 FUSIONPROTEIN VERSUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA - RESULTS OF A RANDOMIZED DOUBLE-BLIND TRIAL

      Journal of clinical oncology
    33. BIERMAN PJ; VOSE JM; ANDERSON JR; BISHOP MR; KESSINGER A; ARMITAGE JO
      HIGH-DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC RESCUE FOR FOLLICULARLOW-GRADE NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    34. TALMADGE JE; REED E; INO K; KESSINGER A; KUSZYNSKI C; HEIMANN D; VARNEY M; JACKSON J; VOSE JM; BIERMAN PJ
      RAPID IMMUNOLOGICAL RECONSTITUTION FOLLOWING TRANSPLANTATION WITH MOBILIZED PERIPHERAL-BLOOD STEM-CELLS AS COMPARED TO BONE-MARROW

      Bone marrow transplantation
    35. ABOUELELLA AA; VOSE JM; ANDERSON JR; BIERMAN PJ; GREINER TC; CHAN WC; ARMITAGE JO; WEISENBURGER DD
      PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 50 CASES

      Laboratory investigation
    36. BUYUKBERBER S; SINGH RK; VARNEY ML; INO K; AGEITOS A; VOSE JM; BIERMAN PJ; TALMADGE JE
      PERIPHERAL STEM-CELL PRODUCTS CONTAIN MONOCYTES WHICH INDUCE APOPTOSIS OF ACTIVATED T-LYMPHOCYTES BY FAS LIGAND EXPRESSION

      Blood
    37. BISHOP MR; TARANTOLO SR; BIERMAN PJ; VOSE JM; ARMITAGE JO; PAVLETIC ZS; REED EC; LYNCH J; KOLLATH J; ZACHARIAS D; SHANNON S; KESSINGER A
      CORRELATION OF MOBILIZATION CHARACTERISTICS OF NORMAL DONORS WITH CLINICAL OUTCOME FOLLOWING ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION

      Blood
    38. PAVLETIC ZS; BIERMAN PJ; TARANTOLO SR; VOSE JM; WU D; REED EC; PIERSON JL; LYNCH J; KESSINGER A; ARMITAGE JO; BISHOP MR
      ALLOGENEIC STEM-CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA(B-CLL)

      Blood
    39. BISHOP MR; SCHMITPOKORNY K; LYNCH J; TARANTOLO SR; BIERMAN PJ; VOSE JM; ARMITAGE JO; PAVLETIC ZS; URSICK M; WARKENTIN PI; REDDY R; KESSINGER A
      FACTORS RESULTING IN THROMBOCYTOPENIA DURING MOBILIZATION AND COLLECTION OF BLOOD STEM-CELLS FROM NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION

      Blood
    40. TARANTOLO SR; BISHOP MR; PAVLETIC ZS; KOLLATH J; LYNCH J; REED EC; BIERMAN PJ; VOSE JM; GROSS TG; ARMITAGE JO; KESSINGER A
      GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC BLOOD STEM-CELLTRANSPLANTATION - RISK FACTOR-ANALYSIS

      Blood
    41. PAVLETIC ZS; TARANTOLO SR; LYNCH JC; KOLLATH JP; REED EC; BIERMAN PJ; VOSE JM; KETCHAM M; GROSS TG; ARMITAGE JO; KESSINGER A; BISHOP MR
      ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION - RESPONSE TO PRIMARY-TREATMENT

      Blood
    42. BRAND RE; DIBAISE JK; HARMON KS; GOBAR L; BISHOP MR; BIERMAN PJ; QUIGLEY EMM; TARANTOLO SR
      THE OCCURRENCE OF GASTROPARESIS FOLLOWING HIGH-DOSE THERAPY AND STEM-CELL TRANSPLANTATION

      Blood
    43. BRAND RE; DIBAISE JK; HARMON KS; BIERMAN PJ; BISHOP MR; QUIGLEY EMM; TARANTOLO SR
      THE USE OF INTRAVENOUS ERYTHROMYCIN TO TREAT NAUSEA, VOMITING AND ANOREXIA FOLLOWING HIGH-DOSE THERAPY AND STEM-CELL TRANSPLANTATION

      Blood
    44. BISHOP MR; TARANTOLO SR; BIERMAN PJ; VOSE JM; ARMITAGE JO; PAVLETIC ZS; LYNCH J; KOLLATH J; REDDY RL; WARKENTIN PI; KESSINGER A
      PREDICTIVE FACTORS FOR THE IDENTIFICATION OF ALLOGENEIC BLOOD STEM-CELL DONORS AS POOR MOBILIZERS PRIOR TO STEM-CELL COLLECTION

      Blood
    45. HAUKE RJ; TARANTOLO SR; BASHIR RM; MORAVEC D; BIERMAN PJ
      CENTRAL-NERVOUS-SYSTEM HODGKINS-DISEASE RELAPSING WITH EOSINOPHILIC PLEOCYTOSIS

      Leukemia & lymphoma
    46. BIERMAN PJ; VOSE JM; LANGNAS AN; RIFKIN RM; HAUKE RJ; SMIR BN; GREINER TC
      HODGKINS-DISEASE FOLLOWING SOLID-ORGAN TRANSPLANTATION

      Annals of oncology
    47. BIERMAN PJ; ANDERSON JR; FREEMAN MB; VOSE JM; KESSINGER A; BISHOP MR; ARMITAGE JO
      HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC RESCUE FOR HODGKINS-DISEASE PATIENTS FOLLOWING FIRST RELAPSE AFTER CHEMOTHERAPY

      Annals of oncology
    48. PAVLETIC ZS; BISHOP MR; BIERMAN PJ; ARMITAGE JO
      BONE-MARROW TRANSPLANTATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND LYMPHOMAS

      Biomedicine & pharmacotherapy
    49. VOSE JM; BIERMAN PJ; ANDERSON JR; HARRISON KA; DALRYMPLE GV; BYAR K; KESSINGER A; ARMITAGE JO
      SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY GALLIUM IMAGING VERSUS COMPUTED-TOMOGRAPHY - PREDICTIVE VALUE IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    50. BISHOP MR; JACKSON JD; OKANEMURPHY B; SCHMITPOKARNY K; VOSE JM; BIERMAN PJ; WARKENTIN PI; ARMITAGE JO; GARRISON L; KESSINGER A
      PHASE-I TRIAL OF RECOMBINANT FUSION PROTEIN PIXY321 FOR MOBILIZATION OF PERIPHERAL-BLOOD CELLS

      Journal of clinical oncology
    51. VOSE JM; ANDERSON JE; BIERMAN PJ; APPELBAUM FR; ANDERSON JR; GARRISON L; LEBSACK ME; ARMITAGE JO
      PHASE I II TRIAL OF PIXY321 TO ENHANCE ENGRAFTMENT FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID MALIGNANCY/

      Journal of clinical oncology
    52. INO K; BIERMAN PJ; VARNEY ML; HEIMANN DG; KUSZYNSKI CA; WALKER SA; TALMADGE JE
      MONOCYTE ACTIVATION BY AN ORAL IMMUNOMODULATOR (BESTATIN) IN LYMPHOMAPATIENTS FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Cancer immunology and immunotherapy
    53. VOSE JM; BIERMAN PJ; RUBY E; REED EC; BISHOP MR; TARANTOLO S; KESSINGER A; ARMITAGE JO
      USE OF CONTINUOUS-INFUSION GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ALONE OR FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR ENHANCE ENGRAFTMENT FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID MALIGNANCIES

      Bone marrow transplantation
    54. SMIR BN; HAUKE RJ; BIERMAN PJ; GROSS TG; DAMORE F; ANDERSON JR; GREINER TC
      MOLECULAR EPIDEMIOLOGY OF DELETIONS AND MUTATIONS OF THE LATENT MEMBRANE-PROTEIN-1 ONCOGENE OF THE EPSTEIN-BARR-VIRUS IN POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS

      Laboratory investigation
    55. WEISENBURGER DD; GASCOYNE RD; BIERMAN PJ; SHENKIER T; HORSMAN D; ANDERSON JR; CHAN WC; GREINER TC; CONNERS JM; VOSE JM; ARMITAGE JO; SANGER WS
      CLINICAL-SIGNIFICANCE OF THE T(14-18)(Q32-Q21) IN FOLLICULAR LARGE-CELL LYMPHOMA (FLCL)

      Laboratory investigation
    56. LACKNER RP; BIERMAN PJ; GALBRAITH TA
      TRACHEOESOPHAGEAL FISTULA DEVELOPING DURING CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA

      Journal of surgical oncology
    57. GROSS TG; BAKER KS; GORDON BG; BIERMAN PJ; GREINER TC; SAMMUT P; HINRICHS SH
      EPSTEIN-BARR-VIRUS (EBV) VIRAL LOAD IN PERIPHERAL-BLOOD LYMPHOCYTES (PBL) CORRELATES WITH RESPONSE TO THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD)

      Blood
    58. TARANTOLO SR; BISHOP MR; KOLLATH J; REED EC; BIERMAN PJ; VOSE JM; NASRATI K; PAVLETIC ZS; ARMITAGE JO; KESSINGER A
      COMPARISON OF THE INCIDENCE AND DISTRIBUTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL OR BONE-MARROW TRANSPLANTATION WITH AND WITHOUT CYTOKINES

      Blood
    59. PAVLETIC ZS; BISHOP MR; JOSHI SS; TARANTOLO SR; PIRRUCCELLO SJ; REED EC; BIERMAN PJ; VOSE JM; GROSS TG; KOLLATH J; NASRATI K; ARMITAGE JO; KESSINGER A
      IMMUNOLOGICAL RECONSTITUTION AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION - FASTER LYMPHOCYTE RECOVERY CORRELATES WITH BETTER SURVIVAL

      Blood
    60. BISHOP MR; TARANTOLO SR; BIERMAN PJ; VOSE JM; REED EC; GROSS TG; PAVLETIC ZS; SPINOLO J; KOLLATH J; NASRATI K; ARMITAGE JO; KESSINGER A
      ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION AND ALLOGENEIC STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES AT A SINGLE INSTITUTION

      Blood
    61. STEWART DA; VOSE JM; WEISENBURGER DD; ANDERSON JR; RUBY EI; BAST MA; BIERMAN PJ; KESSINGER A; ARMITAGE JO
      THE ROLE OF HIGH-DOSE THERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA

      Annals of oncology
    62. YAN Y; CHAN WC; WEISENBURGER DD; ANDERSON JR; BAST MA; VOSE JM; BIERMAN PJ; ARMITAGE JO
      CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF BONE-MARROW INVOLVEMENT IN PATIENTS WITH DIFFUSE AGGRESSIVE B-CELL LYMPHOMA

      Journal of clinical oncology
    63. VAUGHAN WP; KRIS E; VOSE J; BIERMAN PJ; GWILT P; ARMITAGE JO
      PHASE I II STUDY INCORPORATING INTRAVENOUS HYDROXYUREA INTO HIGH-DOSECHEMOTHERAPY FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED AND REFRACTORY INTERMEDIATE-GRADE AND HIGH-GRADE MALIGNANT-LYMPHOMA/

      Journal of clinical oncology
    64. BENNETT CL; ARMITAGE JL; ARMITAGE GO; VOSE JM; BIERMAN PJ; ARMITAGE JO; ANDERSON JR
      COSTS OF CARE AND OUTCOMES FOR HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION FOR LYMPHOID MALIGNANCIES - RESULTS FROM THE UNIVERSITY-OF-NEBRASKA 1987 THROUGH 1991

      Journal of clinical oncology
    65. KESSINGER A; BISHOP MR; JACKSON JD; OKANEMURPHY B; VOSE JM; BIERMAN PJ; REED EC; WARKENTIN PI; ARMITAGE JO; SHARP JG
      ERYTHROPOIETIN FOR MOBILIZATION OF CIRCULATING PROGENITOR CELLS IN PATIENTS WITH PREVIOUSLY TREATED RELAPSED MALIGNANCIES

      Experimental hematology
    66. HAIRE WD; RUBY EI; GORDON BG; PATIL KD; STEPHENS LC; KOTULAK GD; REED EC; VOSE JM; BIERMAN PJ; KESSINGER A; ARMITAGE JO
      MULTIPLE ORGAN DYSFUNCTION SYNDROME IN BONE-MARROW TRANSPLANTATION

      JAMA, the journal of the American Medical Association
    67. ROBINSON LA; DOBSON JR; BIERMAN PJ
      FALLIBILITY OF TRANSTHORACIC NEEDLE-BIOPSY OF ANTERIOR MEDIASTINAL MASSES

      Thorax
    68. MARTIN AR; WEISENBURGER DD; CHAN WC; RUBY EI; ANDERSON JR; VOSE JM; BIERMAN PJ; BAST MA; ARMITAGE JO
      VALUE OF HISTOLOGIC GRADE IN FOLLICULAR LYMPHOMA - AN EVALUATION OF 4METHODS

      Laboratory investigation
    69. PAVLETIC ZS; BISHOP MR; TARANTOLO S; NASRATI K; PIRUCELLO SJ; ZHANG G; BIERMAN PJ; REED EC; VOSE JM; ARMITAGE JO; ANDERSON JR; JOSHI SS; KESSINGER A
      IMMUNOLOGICAL RECOVERY FOLLOWING ALLOGENEIC TRANSPLANTATION WITH PERIPHERAL-BLOOD STEM-CELLS

      Blood
    70. TARANTOLO SR; WALTERS T; REED EC; BISHOP MR; ARMITAGE JO; BIERMAN PJ; VOSE JM; RENNARD SI; KESSINGER A
      CYTOMEGALOVIRUS (CMV) SURVEILLANCE AND INFECTION IN ALLOGENEIC BONE-MARROW AND BLOOD STEM-CELL TRANSPLANTS

      Blood
    71. BISHOP MR; TARANTOLO SR; MARTINALGARRA S; COWLES K; BIERMAN PJ; VOSE JM; REED EC; GROSS TG; ARMITAGE JO; PAVLETIC ZS; NASRATI K; KESSINGER A
      COMPARISON OF HEMATOPOIETIC RECOVERY FOLLOWING ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION AND ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    72. TARANTOLO SR; BISHOP MR; COWLES K; REED EC; BIERMAN PJ; VOSE JM; MARTINALGARRA S; PAVLETIC ZS; NASRATI K; ARMITAGE JO; KESSINGER A
      INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENIC BLOOD STEM-CELL TRANSPLANTATION

      Blood
    73. VOSE JM; BIERMAN PJ; ANDERSON J; BISHOP MR; KESSINGER A; ARMITGE JO
      PATIENTS WITH DIFFUSE AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) TRANSPLANTED WITHIN ONE-YEAR OF INITIAL DIAGNOSIS - IMPROVED OUTCOME WITH TRANSPLANTATION PLANNED AS PART OF INITIAL THERAPY

      Blood
    74. BISHOP MR; TARANTOLO SR; SCHMITPOKORNY K; COWLES K; BIERMAN PJ; VOSE JM; ARMITAGE JO; PAVLETIC ZS; JACKSON J; ZACHARIAS D; NASRATI K; KESSINGER A
      MOBILIZATION OF BLOOD STEM-CELLS FROM HLA-MATCHED RELATED DONORS WITHLOW-DOSE GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ALLOGENEIC TRANSPLANTATION

      Blood
    75. BISHOP MR; OKANEMURPHY B; JACKSON JD; VOSE JM; BIERMAN PJ; ARMITAGE JO; GARRISON L; KESSINGER A
      MOBILIZATION OF BLOOD STEM-CELLS WITH PIXY321 - RESULTS OF A PHASE TRIAL

      Blood
    76. MARTIN AR; WEISENBURGER DD; CHAN VC; RUBY EI; ANDERSON JR; VOSE JM; BIERMAN PJ; BAST MA; DALEY DT; ARMITAGE JO
      PROGNOSTIC VALUE OF CELLULAR PROLIFERATION AND HISTOLOGIC GRADE IN FOLLICULAR LYMPHOMA

      Blood
    77. BIERMAN PJ
      UPDATE OF RESULTS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LYMPHOMA

      Medical oncology
    78. DARRINGTON DL; VOSE JM; ANDERSON JR; BIERMAN PJ; BISHOP MR; CHAN WC; MORRIS ME; REED EC; SANGER WG; TARANTOLO SR; WEISENBURGER DD; KESSINGER A; ARMITAGE JO
      INCIDENCE AND CHARACTERIZATION OF SECONDARY MYELODYSPLASTIC SYNDROME AND ACUTE MYELOGENOUS LEUKEMIA FOLLOWING HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR LYMPHOID MALIGNANCIES

      Journal of clinical oncology
    79. KESSINGER A; BISHOP M; ARMITAGE JO; BIERMAN PJ; REED EC; TARANTOLO S; VOSE JM; WARKENTIN PI
      SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) ADMINISTRATION OF RHGM-CSF FORPERIPHERAL-BLOOD STEM-CELL MOBILIZATION

      Experimental hematology
    80. BISHOP MR; VOSE JM; BIERMAN PJ; ARMITAGE JO; GARRISON L; SCHMITPOKORNY K; KESSINGER A
      PHASE-I TRIAL OF PIXY321 FOR PERIPHERAL STEM-CELL MOBILIZATION IN PATIENTS WITH LYMPHOID MALIGNANCIES

      Experimental hematology
    81. ARMITAGE JO; VOSE JM; BIERMAN PJ; BISHOP MR
      SALVAGE THERAPY FOR PATIENTS WITH LYMPHOMA

      Seminars in oncology
    82. VOSE JM; ANDERSON JR; BIERMAN PJ; BAST M; WEISENBURGER D; CHAN WC; BISHOP MR; ARMITAGE JO
      COMPARISON OF FRONT-LINE CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA USING THE CAP-BOP REGIMENS

      Seminars in hematology
    83. CASEY JH; VOSE JM; CHAN WC; BAST MA; BIERMAN PJ; ARMITAGE JO; WEISENBURGER DD
      PRIMARY GASTRIC NON-HODGKINS-LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 29 CASES

      Laboratory investigation
    84. MARTIN AR; WEISENBURGER DD; VOSE JM; ANDERSON JR; BIERMAN PJ; BAST MA; DALEY DT; ARMITAGE JO; CHAN WC
      PROGNOSTIC VALUE OF CELLULAR PROLIFERATION IN FOLLICULAR LYMPHOMA STUDIED BY IMAGE-ANALYSIS OF FIXED TISSUE STAINED WITH KI-67

      Laboratory investigation
    85. YAN Y; CHAN WC; WEISENBURGER DD; VOSE JM; BIERMAN PJ; BAST MA; ARMITAGE JO
      PROGNOSIS SIGNIFICANCE OF BONE-MARROW INVOLVEMENT IN PATIENTS WITH DIFFUSE AGGRESSIVE B-CELL LYMPHOMA

      Laboratory investigation
    86. MARTINALGARRA S; BIERMAN PJ; ANDERSON J; VOSE J; KESSINGER A; ARMITAGE JO
      CYCLOPHOSPHAMIDE, BCNU, AND VP-16 FOLLOWED BY AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN HODGKIN DISEASE (HD) - RETROSPECTIVE ANALYSIS OF 10 YEARS EXPERIENCE AT THE UNIVERSITY-OF-NEBRASKA MEDICAL-CENTER

      Blood
    87. BIERMAN PJ; VOSE JM; ARMITAGE JO
      AUTOLOGOUS TRANSPLANTATION FOR HODGKINS-DISEASE - COMING OF AGE

      Blood
    88. BISHOP MR; ANDERSON JR; JACKSON JD; BIERMAN PJ; REED EC; VOSE JM; ARMITAGE JO; WARKENTIN PI; KESSINGER A
      HIGH-DOSE THERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON THE AUTOGRAFT

      Blood
    89. METCALF JP; RENNARD SI; REED EC; HAIRE WD; SISSON JH; WALTER T; ROBBINS RA; ARMITAGE JO; ARNESON M; BIERMAN PJ; CURSEEN AF; DARRINGTON D; DICKE KA; HUERTA G; JONES K; KESSINGER A; RICKARD KA; ROMBERGER DJ; RUBENSTEIN I; SHUMWAY M; SPURZEM JR; THOMPSON AB; VAUGHAN WP; VONESSEN SG; VOSE JM; YATES RS
      CORTICOSTEROIDS AS ADJUNCTIVE THERAPY FOR DIFFUSE ALVEOLAR HEMORRHAGEASSOCIATED WITH BONE-MARROW TRANSPLANTATION

      The American journal of medicine
    90. BIERMAN PJ; BAGIN RG; JAGANNATH S; VOSE JM; SPITZER G; KESSINGER A; DICKE KA; ARMITAGE JO
      HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC RESCUE INHODGKINS-DISEASE - LONG-TERM FOLLOW-UP IN 128 PATIENTS

      Annals of oncology
    91. BISHOP MR; BIERMAN PJ; VOSE JM; ARMITAGE JO
      THE ROLE OF HIGH-DOSE THERAPY WITH HEMATOPOIETIC STEM-CELL RESCUE IN LOW-GRADE NON-HODGKINS-LYMPHOMA

      Annals of oncology
    92. BIERMAN PJ; ARMITAGE JO
      ROLE OF AUTOTRANSPLANTATION IN HODGKINS-DISEASE

      Hematology/oncology clinics of North America
    93. VOSE JM; REED EC; PIPPERT GC; ANDERSON JR; BIERMAN PJ; KESSINGER A; SPINOLO J; ARMITAGE JO
      MESNA COMPARED WITH CONTINUOUS BLADDER IRRIGATION AS UROPROTECTION DURING HIGH-DOSE CHEMOTHERAPY AND TRANSPLANTATION - A RANDOMIZED TRIAL

      Journal of clinical oncology
    94. VOSE JM; ANDERSON JR; KESSINGER A; BIERMAN PJ; COCCIA P; REED EC; GORDON B; ARMITAGE JO
      HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    95. NAKAMINE H; BAGIN RG; VOSE JM; BAST MA; BIERMAN PJ; ARMITAGE JO; WEISENBURGER DD
      PROGNOSTIC-SIGNIFICANCE OF CLINICAL AND PATHOLOGICAL FEATURES IN DIFFUSE LARGE B-CELL LYMPHOMA

      Cancer
    96. VOSE JM; WEISENBURGER DD; ANDERSON JR; BIERMAN PJ; BAST M; CHAN WJ; BISHOP MR; ARMITAGE JO
      MANTLE CELL LYMPHOMA (MCL) HAS A POORER PROGNOSIS THAN FOLLICULAR NON-HODGKINS-LYMPHOMA (F-NHL) - HOWEVER, HIGH-DOSE THERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) MAY OVERCOME TREATMENT RESISTANCE IN MCL

      Blood
    97. BENNETT CL; ARMITAGE JL; ARMITAGE GO; SCHWARTZ CE; BIERMAN PJ; VOSE JM; ARMITAGE JO; ANDERSON JR
      A LEARNING-CURVE EXISTS IN AUTOLOGOUS TRANSPLANTATION FOR HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL) AS EVIDENCED BY IMPROVEMENTS IN COST AND IN-HOSPITAL MORTALITY (IHM)

      Blood
    98. BISHOP MR; BIERMAN PJ; VOSE JM; ANDERSON JR; PIERSON JL; FREEMAN MB; KESSINGER A; ARMITAGE JO
      ANALYSIS OF SURVIVAL AND COMPLICATIONS IN HODGKINS-DISEASE PATIENTS OBTAINING COMPLETE REMISSION FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION

      Blood
    99. BISHOP MR; ANDERSON JR; JACKSON JD; BIERMAN PJ; REED EC; VOSE JM; WARKENTIN PI; ARMITAGE JO; KESSINGER A
      EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON MOBILIZATION AND ENGRAFTMENT OF PERIPHERAL-BLOOD PROGENITOR CELLS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 02:03:14